We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.99B
AUM Growth
+$475M
Cap. Flow
-$113M
Cap. Flow %
-1.13%
Top 10 Hldgs %
8.79%
Holding
968
New
62
Increased
353
Reduced
363
Closed
57

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$25M
2
FCNCA icon
First Citizens BancShares
FCNCA
+$23.1M
3
NEWT icon
NewtekOne
NEWT
+$21.4M
4
AGO icon
Assured Guaranty
AGO
+$18.9M
5
TECH icon
Bio-Techne
TECH
+$18.7M

Sector Composition

Rank Sector Weight
1 Industrials 27.54%
2 Technology 18.26%
3 Consumer Discretionary 12.96%
4 Financials 12.6%
5 Materials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASIX icon
701
AdvanSix
ASIX
$540M
$1.6M 0.02%
41,753
+3,956
+10% +$158K
GROW icon
702
US Global Investors
GROW
$35.5M
$1.6M 0.02%
604,954
SUPN icon
703
Supernus Pharmaceuticals
SUPN
$2.59B
$1.58M 0.02%
43,619
-184
-0.4% -$7.08K
MYRG icon
704
MYR Group
MYRG
$5.3B
$1.56M 0.02%
12,405
+1,708
+16% +$184K
GEG icon
705
Great Elm Group
GEG
$69M
$1.55M 0.02%
682,245
PCTY icon
706
Paylocity
PCTY
$7.31B
$1.55M 0.02%
7,786
BIOX icon
707
Bioceres Crop Solutions
BIOX
$21.8M
$1.54M 0.02%
133,000
FC icon
708
Franklin Covey
FC
$240M
$1.54M 0.02%
40,100
-11,100
-22% -$512K
AAOI icon
709
Applied Optoelectronics
AAOI
$7.69B
$1.54M 0.02%
697,210
+295,358
+73% +$724K
NNBR icon
710
NN Inc
NNBR
$255M
$1.54M 0.02%
1,439,308
-764,579
-35% -$1.36M
MXCT icon
711
MaxCyte
MXCT
$112M
$1.52M 0.02%
307,925
+37,800
+14% +$186K
YELP icon
712
Yelp
YELP
$1.45B
$1.51M 0.02%
49,310
+14,676
+42% +$441K
SM icon
713
SM Energy
SM
$7.71B
$1.51M 0.02%
53,658
+27,332
+104% +$834K
USNA icon
714
Usana Health Sciences
USNA
$407M
$1.48M 0.01%
23,507
+2,547
+12% +$152K
GDEN
715
DELISTED
Golden Entertainment
GDEN
$1.48M 0.01%
33,917
+3,538
+12% +$143K
VERX icon
716
Vertex
VERX
$2.07B
$1.47M 0.01%
+71,000
New +$1.09M
EXPR
717
DELISTED
Express, Inc.
EXPR
$1.47M 0.01%
93,143
-180
-0.2% -$3.64K
FLG
718
Flagstar Bank National Association
FLG
$5.96B
$1.46M 0.01%
53,816
-27,061
-33% -$732K
LGTY
719
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.46M 0.01%
115,684
-323
-0.3% -$4.54K
EVTC icon
720
Evertec
EVTC
$1.89B
$1.44M 0.01%
42,572
+4,200
+11% +$148K
GOOS
721
Canada Goose Holdings
GOOS
$877M
$1.42M 0.01%
+74,000
New +$1.46M
VALU icon
722
Value Line
VALU
$354M
$1.42M 0.01%
29,470
FLGT icon
723
Fulgent Genetics
FLGT
$483M
$1.42M 0.01%
45,549
+19,791
+77% +$637K
DSP icon
724
Viant Technology
DSP
$230M
$1.42M 0.01%
326,029
+306,729
+1,589% +$1.33M
LOB icon
725
Live Oak Bancshares
LOB
$1.97B
$1.41M 0.01%
57,845
+8,100
+16% +$254K

Similar funds

Royce & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Royce & Associates held 968 positions worth $9.99B, up 5% from $9.52B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Royce & Associates's Q1 2023 filing shows 62 new, 353 increased, 363 reduced and 57 closed positions. Its largest new stake was Innovex International: 284,752 shares worth $8.17M. The largest sale was Interparfums, an estimated $35.1M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q1 2023 buy was Innovex International: 284,752 shares worth $8.17M.
  • Royce & Associates added most to RB Global in Q1 2023, an estimated $25M increase.
  • Royce & Associates's biggest Q1 2023 reduction was Interparfums, cutting an estimated $35.1M.
  • Royce & Associates fully exited nVent Electric in Q1 2023, selling an estimated $7.89M.
  • Royce & Associates's ten largest holdings make up 8.8% of its $9.99B portfolio in Q1 2023.
  • Royce & Associates opened 62 new positions and closed 57 in Q1 2023.
  • Royce & Associates's portfolio value rose 5% quarter-over-quarter to $9.99B.

Based on Royce & Associates's 13F filing for Q1 2023, filed 4 May 2023.